Epidermal growth factor receptor (EGFR) is a kind of tyrosine kinase receptor. The EGFR gene amplification
reassortment and mutation lead to overexpress of EGFR protein
which is the common genetic variation of primary glioblastoma. The common oncological detection of molecular pathology is unable to test the patients without pathological specimens for some reasons. Positron emission tomography can test the lesions by imaging. According to the biochemical characters of EGFR
EGFR-targeted imaging agents are divided into radiolabeled tyrosine kinase inhibitor and radiolabeled monoclonal antibody.
Predictors of pathological grade in patients with brain stem glioma and its relationship with APT imaging
The non-invasive prediction analysis of radiomic features from 18 F-FET PET/CT dual imaging modality for tumor grading in untreated adult gliomas
Advances and prospects of PET/MRI of brain tumors
The value of 18 F-FDG PET/CT radiomic features for predicting EGFR gene mutation status in patients with lung adenocarcinoma
Research progress of amide proton transfer imaging in preoperative grading and postoperative recurrence assessment of glioma
Related Author
LIN Huiqing
HUANG Li
LIN Li
TANG Yilin
HUA Tao
ZHOU Weiyan
ZHOU Zhirui
HUANG Qi
Related Institution
Department of Radiotherapy, Huashan Hospital, Fudan University
Department of Nuclear Medicine/PET Center, Huashan Hospital, Fudan University
Medical Imaging School, North Sichuan Medical College, Nanchong
Department of Nuclear Medicine, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China
Department of Neurology, Shenzhen Longhua People&rsquo